Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving early Alzheimer’s diagnosis. Unlike amyloid-beta, tau neurofibrillary ...

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their resemblance to healthy tissue.

Researchers combined animal models, human brain tissue, and molecular analysis to uncover a connection between Alzheimer's ...

People who carry a certain variation of this repeated DNA sequence have more than double the risk (2.2 times higher)of ...

Now researchers from The Rockefeller University have unearthed intriguing genetic evidence: a protein variant found only in ...

Neurogeneticists have discovered a novel genetic mutation and associated buildup of toxic proteins in the brain -- a type of buildup distinct from amyloid or tau, proteins that have long been the ...

The preliminary data presented in this manuscript seem valuable. The data are currently incomplete and there are numerous technical concerns, some of which may arise from insufficient description of ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...